Cleviprex approved in US

The FDA has approved The Medicines Company’s ca channel blocker Cleviprex for the IV treatment of hypertension

Cleviprex effective in the treatment of Acute Hypertension After Cardiac Surgery

Phase III data shows that The Medicines Company’s drug Cleviprex (clevidipine butyrate) is effective and safe in the rapid treatment of acute hypertension after cardiac surgery.

Cleviprex controls perioperative hypertension, may reduce heart attack

Data presented at the SCA Meeting show The Medicine Company’s Calcium channel antagonist Cleviprex injectable may reduce the risk of heart attack compared to two other antihypertensive agents.

Cleviprex shown to reduce and control high blood pressure in elderly patients

Cleviprex (clevidipine), produced The Medicines Company, has been shown to rapidly achieve and maintain blood pressure control in patients with acutely elevated blood pressure

Clevidipine to enter new Phase III trial for Acute Hypertension and Intracerebral Hemorrhage

A forthcoming Phase III trial of Clevidipine (Clevelox, Cleviprex) for Acute Hypertension and Intracerebral Hemorrhage is being carried out by The Medicines Company.